Boosted lopinavir–versus boosted atazanavir–containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries
Citation:
Boosted lopinavir–versus boosted atazanavir–containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Clinical Infectious Diseases. 2015;60:1262–1268.
Dept. of Hygiene, Epidemiology and Medical Statistics School of Medicine National and Kapodistrian University of Athens 75, M.Asias Str. Athens 11527, Greece Tel.: +30 210 7462088 npantaz@med.uoa.gr
